Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours-Reference-Cited by-同舟云学术

Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours

Published:2011-02-01 Issue:3 Volume:71 Page:437-444
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gusella Milena,Pasini Felice,Bolzonella Caterina,Meneghetti Silvia,Barile Carmen,Bononi Antonio,Toso Silvia,Menon Daniela,Crepaldi Giorgio,Modena Yasmina,Stievano Laura,Padrini Roberto

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2010.03838.x/fullpdf

Reference30 articles.

1. Clinical pharmacology and pharmacogenetics of gemcitabine;Wong;Drug Metab Rev,2009

2. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine;Abbruzzese;J Clin Oncol,1991

3. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy;Damaraju;Oncogene,2003

4. Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1;Myers;Pharmacogenet Genomics,2006

5. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations;Gray;Mol Pharmacol,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance;Cell Reports;2024-07

2. Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance in a p53-dependent manner;2023-01-02

3. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype;Clinical and Translational Science;2021-04-03

4. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma;European Journal of Medicinal Chemistry;2021-03

5. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines;Drug Metabolism and Disposition;2019-12-23